Diabetes Control: Save 20% on Monitoring & Pre-Diabetes Tests

 The DH-1 Diabetes Health panel is specifically curated to provide a foundational assessment of an individual's diabetes status and metabolic health. It includes two essential tests: the Comprehensive Metabolic Panel (CMP) and the Hemoglobin A1c (HbA1c). This panel is designed to give a snapshot of the current glucose control and the body's metabolic state, offering crucial insights for managing diabetes effectively.

Specimen Type: Serum, Blood

The DH-2 Diabetes Health panel is an expanded diagnostic tool designed for comprehensive diabetes management and assessment of related health risks. It includes a range of tests: CBC with Differential and Platelets, Comprehensive Metabolic Panel (CMP), Hemoglobin A1c, Lipid Panel, and Random Urine Microalbumin with Creatinine. This panel provides a detailed view of a patient's blood sugar control, kidney function, liver function, lipid levels, and overall health status, making it a valuable resource in managing diabetes and its complications.

Specimen Type: Blood, Serum

The DH-3 Diabetes Health panel is a comprehensive diagnostic panel designed for an in-depth analysis of diabetes management and its impact on overall health. It includes a series of tests: C-Reactive Protein (CRP), CBC with Differential and Platelets, Comprehensive Metabolic Panel (CMP), Hemoglobin A1c, Insulin, Lipid Panel, and Random Urine Microalbumin with Creatinine. This panel not only assesses blood sugar control and diabetes management but also evaluates cardiovascular risk, kidney function, and the body's insulin production and response.

Specimen Type: Serum, Blood

 The DH-4 Diabetes Health panel is a comprehensive suite of tests tailored for individuals with diabetes, particularly those with complex management needs or those at high risk for complications. This panel includes C-Reactive Protein (CRP), CBC with Differential and Platelets, Comprehensive Metabolic Panel (CMP), 2 Specimen Glucose Tolerance Test, Hemoglobin A1c, Insulin, 2 Specimen Insulin Response to Glucose, Lipid Panel, and Random Urine Microalbumin with Creatinine. It is designed to provide a thorough assessment of diabetes control, cardiovascular risk, insulin function, kidney health, and overall metabolic status.

Specimen Type: Blood, Serum, Plasma-Unspecified Vial Pour

Specimen Type: Serum

Specimen Type: Serum

Specimen Type: Serum, Random

Specimen Type: Random, Serum

The Hemoglobin A1c (HbA1c) Test measures average blood glucose over 2–3 months by detecting sugar attached to hemoglobin in red blood cells. It is used to diagnose diabetes, identify prediabetes, and monitor long-term blood sugar control. Doctors rely on the HbA1c test to evaluate treatment effectiveness, guide adjustments, and assess risk for complications, making it essential for diabetes care and metabolic health screening.

Specimen Type: Blood

The Comprehensive Metabolic Panel (CMP) Test measures 21 markers to assess metabolic health, liver and kidney function, and electrolyte balance. It includes glucose, calcium, sodium, potassium, chloride, CO2, albumin, globulin, A/G ratio, total protein, bilirubin, ALP, AST, ALT, BUN, creatinine, BUN/creatinine ratio, and eGFR. The CMP helps detect diabetes, liver or kidney disease, and supports routine screening and chronic condition monitoring.

Specimen Type: Serum

The Complete Blood Count with Differential and Platelets Test is a comprehensive blood test that checks red blood cells, white blood cells, hemoglobin, hematocrit, and platelets. The differential analyzes types of white blood cells to detect infections, anemia, clotting abnormalities, immune conditions, and certain cancers. This essential test is often ordered for routine health exams, diagnosis, and monitoring treatment progress.

Specimen Type: Blood

The Lipid Panel Test checks six key blood lipids: total cholesterol, HDL cholesterol, LDL cholesterol, non-HDL cholesterol, triglycerides, and the Chol/HDL ratio. This panel assesses risk for cardiovascular disease, heart attack, and stroke by evaluating cholesterol balance and fat levels in the blood. Doctors use lipid panel results for routine screening, treatment monitoring, and guiding lifestyle or medication adjustments.

The Albumin Random Urine Test with Creatinine measures albumin and creatinine levels in a urine sample to evaluate kidney health. Elevated albumin (microalbuminuria) may indicate early kidney disease, diabetes complications, or hypertension-related damage. Doctors use this test to detect kidney problems before symptoms appear, monitor chronic conditions, and guide treatment. It provides vital insight into renal function and long-term kidney disease management.

The Insulin Test measures insulin levels in blood to assess how the body regulates glucose and metabolism. It helps diagnose insulin resistance, hypoglycemia, type 2 diabetes, and metabolic syndrome. Doctors also use it to evaluate pancreatic function and monitor treatment effectiveness. Frequently ordered with glucose testing, the insulin test provides critical insight into endocrine health, blood sugar control, and risk for diabetes-related complications.

Specimen Type: Serum

The C-Reactive Protein (CRP) Test measures CRP levels in blood to detect inflammation in the body. Elevated CRP may indicate infections, autoimmune disorders, or chronic diseases such as arthritis, cardiovascular disease, or inflammatory bowel disease. Doctors use this test to assess acute illness, monitor treatment response, and evaluate risk for heart disease. The CRP test provides key insight into inflammation, immune health, and overall wellness.

Specimen Type: Serum

The Glucose Tolerance Test, 2 Specimens, is a specialized diagnostic tool that provides valuable insights into an individual's ability to regulate blood sugar levels over a specific period. This test involves multiple blood samples taken before and after consuming a glucose-rich solution. It is a critical assessment for diagnosing conditions like diabetes and evaluating the body's response to glucose.

Specimen Type: Plasma-Unspecified Vial Pour

 The Insulin Response to Glucose 2 Specimens test is a specialized laboratory assay designed to assess the body's response to glucose intake and the subsequent insulin production. This test involves measuring insulin levels in response to glucose challenge, helping to evaluate insulin sensitivity and detect early signs of impaired glucose metabolism.

Specimen Type: Serum

The Glutamic Acid Decarboxylase-65 (GAD65) Antibody Test detects antibodies against the GAD65 enzyme, often linked to autoimmune type 1 diabetes and latent autoimmune diabetes in adults (LADA). Positive results indicate immune-related damage to insulin-producing beta cells. Doctors use this test to distinguish type 1 from type 2 diabetes, evaluate unexplained hyperglycemia, and assess risk in patients with suspected autoimmune endocrine disorders.

Specimen Type: Serum

 The Proinsulin test measures the amount of proinsulin in the blood. Proinsulin is a precursor molecule to insulin, a hormone produced by the pancreas' beta cells. After its production, proinsulin gets split into two parts: insulin and C-peptide. While insulin aids in glucose uptake by cells, proinsulin itself is typically present in very low levels in the blood.

Specimen Type: Serum

The Adiponectin test measures the concentration of adiponectin—a hormone secreted by adipose tissue—in the blood. Adiponectin plays a significant role in regulating insulin sensitivity, glucose metabolism, inflammation, and lipid metabolism. This test provides insights into the individual's metabolic health and risk of various metabolic disorders.

Specimen Type: Serum

The Urinalysis Complete Test evaluates urine for physical, chemical, and microscopic properties to assess kidney health, urinary tract infections, diabetes, and metabolic disorders. It measures appearance, concentration, pH, protein, glucose, ketones, blood, bilirubin, nitrites, leukocyte esterase, and microscopic cells or crystals. Doctors use this test in routine exams, to diagnose urinary symptoms, and to monitor chronic kidney or metabolic disease.

Specimen Type: Random

The C-Peptide Test measures C-peptide levels in blood to assess insulin production and pancreatic function. Low levels may indicate type 1 diabetes or reduced insulin production, while high levels may suggest type 2 diabetes, insulin resistance, or insulinoma. Doctors use this test to differentiate diabetes types, monitor treatment, and evaluate unexplained hypoglycemia. It provides key insight into endocrine, pancreatic, and metabolic health.

Specimen Type: Serum

The Fructosamine Test measures average blood glucose levels over the past 2–3 weeks by evaluating glycated proteins. Unlike the HbA1c test, which reflects long-term control, this test provides a shorter-term view, making it useful for monitoring recent treatment changes, pregnancy, or conditions affecting red blood cells. Doctors use it to assess diabetes management, adjust medications, and evaluate how well blood sugar is being controlled.

Specimen Type: Serum

The Apolipoprotein A1 and B Test measures Apo A1, the main protein in HDL cholesterol, and Apo B, the primary protein in LDL and VLDL cholesterol. Together, these markers and the ApoB/A1 ratio provide a clearer picture of cardiovascular risk than standard lipid panels. High ApoB or low Apo A1 may signal heart disease, stroke, or atherosclerosis. Doctors use this test to evaluate cholesterol balance, monitor therapy, and guide prevention of cardiovascular conditions.

Specimen Type: Serum

The Cardio IQ™ Lipoprotein Fractionation Ion Mobility Test separates and measures lipoprotein particles by size and concentration using ion mobility technology. It provides a detailed profile of LDL, HDL, and other subclasses, offering a clearer assessment of cardiovascular risk than standard cholesterol testing.

Specimen Type: Serum